Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Sangamo to present 9 abstracts at ASGCT 2025, showcasing breakthroughs in neurology and gene regulation

Written by | 30 Apr 2025

Sangamo Therapeutics, Inc. , a genomic medicine company, announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted nine Sangamo abstracts for presentation at the… read more.

Metabolic syndrome linked to young-onset dementia

Written by | 24 Apr 2025

Metabolic syndrome appears to be linked to onset of dementia before age 65, also known as young-onset dementia. Researchers reported the findings on April 23, 2025 in Neurology…. read more.

Common genetic variants linked to drug-resistant epilepsy

Written by | 22 Apr 2025

Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global study led by researchers at UCL and UTHealth… read more.

Update on regulatory review of lecanemab for early Alzheimer’s disease by the European Commission – Eisai

Written by | 21 Apr 2025

Eisai Co., Ltd. and Biogen Inc. announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as a treatment for early AD (mild… read more.

Popular diabetes medications, including GLP-1 drugs, may protect against Alzheimer’s disease

Written by | 20 Apr 2025

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the… read more.

Investigational tolebrutinib shows efficacy for non-relapsing secondary progressive multiple sclerosis (SPMS)

Written by | 12 Apr 2025

Results from a Phase 3 study of treatment with investigational tolebrutinib show a 31% delay in the onset of six-month confirmed disability progression (CDP) in patients with non-relapsing… read more.

Exposure to air pollution may harm brain health of older adults

Written by | 9 Apr 2025

Long-term exposure to high levels of air pollution may harm the brain health of older adults in England, finds a new study led by UCL researchers. The research,… read more.

Lundbeck to present new data on Bexicaserin for developmental and epileptic encephalopathies and Eptinezumab in migraine at AAN 2025

Written by | 7 Apr 2025

H. Lundbeck A/S (Lundbeck) announced that recent pipeline data will be presented at the 2025 AAN Annual Meeting in San Diego, U.S. The data includes an oral presentation… read more.

Xenon Pharmaceuticals to present new long-term data for Azetukalner in focal onset seizures at AAN 2025

Written by | 6 Apr 2025

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced multiple presentations at the upcoming American Academy of… read more.

LDL cholesterol and statin therapy linked to dementia

Written by | 4 Apr 2025

Compared with people with elevated levels of low-density lipoprotein cholesterol (LDL-C), researchers report that people with lower levels of LDL-C have a relatively lower risk of developing dementia…. read more.

Risk of dementia increases with mid-life AF diagnosis

Written by | 3 Apr 2025

Researchers report a significantly increased risk of dementia in patients diagnosed with atrial fibrillation (AF) in midlife, and a significantly increased risk of early-onset dementia (EOD) as well…. read more.

Could vaping be linked to spinal cord infarct?

Written by | 1 Apr 2025

29th EAHP Congress highlights Cigarette smoking is a well-recognised risk factor for stroke and measures to reduce the prevalence of cigarette smoking have been implemented in many countries…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.